Akihiro Nasu
Overview
Explore the profile of Akihiro Nasu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takeda H, Nishijima N, Nasu A, Komekado H, Kita R, Kimura T, et al.
Hepatol Res
. 2018 Dec;
49(5):594-599.
PMID: 30499247
Lenvatinib is a novel multikinase inhibitor that has recently shown antitumor activity against hepatocellular carcinoma (HCC) in a phase III trial. We report the case of a woman in whom...
2.
Akahane T, Kurosaki M, Itakura J, Tsuji K, Joko K, Kimura H, et al.
Hepatol Res
. 2018 Sep;
49(3):264-270.
PMID: 30171740
Aim: This study aimed to describe the real-world efficacy and safety of sofosbuvir (SOF) + ribavirin (RBV) for chronic hepatitis C, genotype 2. Methods: This was a retrospective analysis of...
3.
Nishijima N, Nasu A, Kimura T, Osaki Y
Intern Med
. 2018 Aug;
58(2):225-231.
PMID: 30146562
We experienced two cases of hepatocellular carcinoma (HCC) occurring immediately after treatment with direct-acting antiviral agents (DAAs). Case 1 was a 75-year-old woman in whom HCC was detected immediately after...
4.
Fujii H, Kimura H, Kurosaki M, Hasebe C, Akahane T, Yagisawa H, et al.
Hepatol Res
. 2018 Feb;
48(9):746-756.
PMID: 29480939
Aim: To evaluate the virologic responses and clinical course of daclatasvir plus asunaprevir treatment in non-hemodialysis (non-HD) and hemodialysis (HD) patients infected with genotype 1 hepatitis C virus (HCV). Methods:...
5.
Yamashina T, Tumura T, Maruo T, Matsumae T, Yoshida H, Tanke G, et al.
Endosc Int Open
. 2018 Jan;
6(1):E111-E114.
PMID: 29344571
Rectal neuroendocrine tumors grade 1 (NET G1; carcinoid) ≤ 10 mm in diameter often extend into the submucosa, making their complete histological resection difficult using endoscopic techniques. Endoscopic submucosal resection...
6.
Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, et al.
Oncol Lett
. 2017 Aug;
14(2):1637-1647.
PMID: 28789390
The present study aimed to examine the impact of sarcopenia, defined as low muscle mass on computed tomography (CT), prior to sorafenib therapy on the clinical outcomes of patients with...
7.
Yamashina T, Fukuhara M, Maruo T, Tanke G, Marui S, Sada R, et al.
Endosc Int Open
. 2017 Jul;
5(7):E587-E594.
PMID: 28670615
Background And Study Aims: Cold snare polypectomy (CSP) for small colorectal polyps has lower incidence of adverse events, especially delayed postpolypectomy bleeding (DPPB). However, few data are available on comparisons...
8.
Takeda H, Ueda Y, Inuzuka T, Yamashita Y, Osaki Y, Nasu A, et al.
Sci Rep
. 2017 Apr;
7:45605.
PMID: 28361915
Resistance-associated variant (RAV) is one of the most significant clinical challenges in treating HCV-infected patients with direct-acting antivirals (DAAs). We investigated the viral dynamics in patients receiving DAAs using third-generation...
9.
Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, et al.
J Cancer
. 2017 Mar;
8(3):378-387.
PMID: 28261338
Aims: To investigate variables before sorafenib therapy on the clinical outcomes in hepatocellular carcinoma (HCC) patients receiving sorafenib and to further assess and compare the predictive performance of continuous parameters...
10.
Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, et al.
J Cancer
. 2017 Mar;
8(2):152-161.
PMID: 28243319
Aims: We sought to compare the effects of FIB-4 index and aspartate aminotransferase to platelet ratio index (APRI) on hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients undergoing...